- Home
- CHMI vs ASRT Comparison
CHMI vs ASRT Comparison
Compare CHMI & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHMI
- ASRT
- Stock Information
- Founded
- CHMI 2012
- ASRT 1995
- Country
- CHMI United States
- ASRT United States
- Employees
- CHMI N/A
- ASRT N/A
- Industry
- CHMI Real Estate Investment Trusts
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- CHMI Real Estate
- ASRT Health Care
- Exchange
- CHMI Nasdaq
- ASRT Nasdaq
- Market Cap
- CHMI 92.0M
- ASRT 85.1M
- IPO Year
- CHMI 2013
- ASRT 1997
- Fundamental
- Price
- CHMI $3.32
- ASRT $0.81
- Analyst Decision
- CHMI Buy
- ASRT Strong Buy
- Analyst Count
- CHMI 3
- ASRT 4
- Target Price
- CHMI $5.00
- ASRT $3.19
- AVG Volume (30 Days)
- CHMI 315.5K
- ASRT 419.9K
- Earning Date
- CHMI 03-06-2025
- ASRT 03-10-2025
- Dividend Yield
- CHMI 18.05%
- ASRT N/A
- EPS Growth
- CHMI N/A
- ASRT N/A
- EPS
- CHMI N/A
- ASRT N/A
- Revenue
- CHMI N/A
- ASRT $125,763,000.00
- Revenue This Year
- CHMI N/A
- ASRT N/A
- Revenue Next Year
- CHMI $27.78
- ASRT $1.84
- P/E Ratio
- CHMI N/A
- ASRT N/A
- Revenue Growth
- CHMI N/A
- ASRT N/A
- 52 Week Low
- CHMI $2.50
- ASRT $0.73
- 52 Week High
- CHMI $3.99
- ASRT $1.80
- Technical
- Relative Strength Index (RSI)
- CHMI 73.18
- ASRT 43.42
- Support Level
- CHMI $3.07
- ASRT $0.79
- Resistance Level
- CHMI $3.33
- ASRT $0.85
- Average True Range (ATR)
- CHMI 0.09
- ASRT 0.03
- MACD
- CHMI 0.04
- ASRT 0.00
- Stochastic Oscillator
- CHMI 91.67
- ASRT 42.86
About CHMI Cherry Hill Mortgage Investment Corporation
Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.